[HTML][HTML] Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping
K Neveling, T Mantere, S Vermeulen… - The American Journal of …, 2021 - cell.com
Somatic structural variants (SVs) are important drivers of cancer development and
progression. In a diagnostic set-up, especially for hematological malignancies, the …
progression. In a diagnostic set-up, especially for hematological malignancies, the …
[HTML][HTML] Clinical validation and diagnostic utility of optical genome mapping for enhanced cytogenomic analysis of hematological neoplasms
NS Sahajpal, AK Mondal, T Tvrdik, J Hauenstein… - The Journal of Molecular …, 2022 - Elsevier
The current standard-of-care cytogenetic techniques for the analysis of hematological
malignancies include karyotyping, fluorescence in situ hybridization, and chromosomal …
malignancies include karyotyping, fluorescence in situ hybridization, and chromosomal …
Optical genome mapping for structural variation analysis in hematologic malignancies
AC Smith, K Neveling… - American journal of …, 2022 - Wiley Online Library
Optical genome mapping (OGM) is a technology that is rapidly being adopted in clinical
genetics laboratories for its ability to detect structural variation (eg, translocations …
genetics laboratories for its ability to detect structural variation (eg, translocations …
[HTML][HTML] Optical genome mapping for cytogenetic diagnostics in AML
Simple Summary Today, the classification of acute myeloid leukemia is mainly based on
genetic aberrations found in leukemic cells. Classifying this disease is necessary for exact …
genetic aberrations found in leukemic cells. Classifying this disease is necessary for exact …
Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients
WM Gerding, M Tembrink… - … Journal of Cancer, 2022 - Wiley Online Library
Cytogenetic diagnostics play a crucial role in risk stratification and classification of myeloid
malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) …
malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) …
Optical genome mapping in acute myeloid leukemia: a multicenter evaluation
Detection of hallmark genomic aberrations in acute myeloid leukemia (AML) is essential for
diagnostic subtyping, prognosis, and patient management. However, cytogenetic …
diagnostic subtyping, prognosis, and patient management. However, cytogenetic …
Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias
V Lestringant, N Duployez, D Penther… - Genes …, 2021 - Wiley Online Library
Acute lymphoblastic leukemias (ALL) are characterized by a large number of cytogenetic
abnormalities of clinical interest that require the use of several complementary techniques …
abnormalities of clinical interest that require the use of several complementary techniques …
[HTML][HTML] Optical genome mapping enables constitutional chromosomal aberration detection
T Mantere, K Neveling, C Pebrel-Richard… - The American Journal of …, 2021 - cell.com
Chromosomal aberrations including structural variations (SVs) are a major cause of human
genetic diseases. Their detection in clinical routine still relies on standard cytogenetics …
genetic diseases. Their detection in clinical routine still relies on standard cytogenetics …
[HTML][HTML] Optical genome mapping as a next-generation cytogenomic tool for detection of structural and copy number variations for prenatal genomic analyses
Global medical associations (ACOG, ISUOG, ACMG) recommend diagnostic prenatal testing
for the detection and prevention of genetic disorders. Historically, cytogenetic methods such …
for the detection and prevention of genetic disorders. Historically, cytogenetic methods such …
[HTML][HTML] Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia
EJ Duncavage, HJ Abel, P Szankasi, TW Kelley… - Modern pathology, 2012 - Elsevier
Leukemias are currently subclassified based on the presence of recurrent cytogenetic
abnormalities and gene mutations. These molecular findings are the basis for risk-adapted …
abnormalities and gene mutations. These molecular findings are the basis for risk-adapted …
相关搜索
- genome mapping comprehensive assessment
- genome mapping cytogenetic diagnostics
- genome mapping hematologic malignancies
- optical genome mapping number variations
- cytogenetic tool hematologic malignancies
- genome mapping clinical utility
- genome scanning cytogenetic tool
- genome mapping promising alternative
- genome mapping multicenter evaluation
- genome mapping genomic aberrations
- genome mapping variation analysis
- genome scanning hematologic malignancies